Shanghai Pharmaceuticals introduced a new antacid drug P-CAB for RMB 690 million, and the competitive landscape continues to be reshaped
Minova received the "Drug Registration Certificate" for Rosuvastatin Calcium Tablets and Atorvastatin Calcium Tablets
Shanghai Pharmaceuticals Rosuvastatin Calcium Tablets Approved for Production
New antacid drugs!
Studies have shown that prescribed antacids are associated with an increased risk of allergies
5 billion varieties! New recruits of rosuvastatin in Jingxin pharmaceutical
Jingxin pharmaceutical: rosuvastatin calcium dispersible tablets obtained the approval of drug registration
The market of rosuvastatin is treacherous. Who entered despite difficulties?
[hot spot] analysis of enterprises for consistency evaluation of rosuvastatin calcium tablets
289 catalog products listed, and the "tripartite confrontation" situation of rosuvastatin calcium tablets has become
The market for rosuvastatin is set? Zhejiang Haizheng passed the consistency evaluation
[exclusive] progress analysis of the consistency evaluation of rosuvastatin calcium tablets, there are soldiers in front of the mountain and behind the mountain
Rosuvastatin calcium Drug Report
Ramsey is approved to sell rosuvastatin in Canada